In this study, we demonstrate that SREBP1 binds to the promoter, and induces the expression of GS resulting in lipid droplet (LD) formation through O-GlcNAc-Sp1/SREBP1/ACC1 signaling in liver and breast cancer cells. Here, SREBF1 is linked to breast carcinoma.